Spatiotemporal expression of heparanase during human and rodent ovarian folliculogenesis

Biology of Reproduction

Volumn 73, Issue 1, 2005, Pages 20-28

  Haimov Kochman, Ronit ^a   Prus, Diana ^a   Zcharia, Eyal ^a   Goldman Wohl, Debra S ^a   Natanson Yaron, Shira ^a   Greenfield, Caryn ^a   Anteby, Eyal Y ^a   Reich, Reuven ^b   Orly, Joseph ^b   Tsafriri, Alex ^c   Hurwitz, Arye ^a   Vlodavsky, Israel ^d   Yagel, Simcha ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Basic fibroblast growth factor; Corpus luteum; Follicle; Granulosa cells; Heparanase; Ovary; Theca cells

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; HEPARANASE; MESSENGER RNA; PROTEOHEPARAN SULFATE; STEROID HORMONE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORPUS LUTEUM; ENZYME ACTIVITY; ENZYME RELEASE; EXTRACELLULAR MATRIX; FEMALE; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUTEOLYSIS; MACROPHAGE; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THECA CELL;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANIMALS; BASEMENT MEMBRANE; CORPUS LUTEUM; EXTRACELLULAR MATRIX; FEMALE; GLUCURONIDASE; GRANULOSA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LUTEINIZATION; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OVARIAN FOLLICLE; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RODENTIA;

EID: 20844457160     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.104.036780     Document Type: Article

References (44)

1. Wight TN, Kinsella MG, Qwarnstrom EE. The role of proteoglycans in cell adhesion, migration and proliferation. Curr Opin Cell Biol 1992; 4:793-801.
2. Vlodavsky I, Bar-Shavit R, Korner G, Fuks Z. Extracellular matrix-bound growth factors, enzymes and plasma proteins. In: Rohrbach DH, Timpl R (eds.), Basement Membranes: Cellular and Molecular Aspects. Orlando, FL: Academic Press Press; 1993:327-343.
3. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998; 67:609-652.
4. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68:729-777.
5. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L, Pecker A. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 1999; 5:793-802.
6. Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, Parish CR. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 1999; 5:803-809.
7. Vlodavsky I, Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 2001; 108:341-347.
8. Parish CR, Freeman C, Hulett MD. Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 2001; 1471:M99-M108.
9. Dempsey LA, Brunn GJ, Platt JL. Heparanase, a potential regulator of cell-matrix interactions. Trends Biochem Sci 2000; 25:349-351.
10. Nakajima M, Irimura T, Nicolson GL. Heparanases and tumor metastasis. J Cell Biochem 1988; 36:157-167.
11. Elkin M, Ilan N, Ishai-Michaeli R, Friedmann Y, Papo O, Pecker I, Vlodavsky I. Heparanase as mediator of angiogenesis: mode of action. FASEB J 2001; 15:1661-1663.
12. Haimov-Kochman R, Friedmann Y, Prus D, Goldman-Wohl DS, Greenfield C, Anteby EY, Aviv A, Vlodavsky I, Yagel S. Localization of heparanase in normal and pathological human placenta. Mol Hum Reprod 2002; 8:566-573.
13. Redmer DA, Doraiswamy V, Bortnem BJ, Fisher K, Jablonka-Shariff A, Grazul-Bilska AT, Reynolds LP. Evidence for the role of capillary pericytes in vascular growth of the developing ovine corpus luteum. Biol Reprod 2001; 65:879-889.
14. Fraser HM, Wulff C. Angiogenesis in the primate ovary. Reprod Fertil Dev 2001; 13:557-566.
15. Geva E, Jaffe RB. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 2000; 74:429-438.
16. Reynolds LP, Grazul-Bilska AT, Killilea SD, Redmer DA. Mitogenic factors of corpora lutea. Prog Growth Factor Res 1994; 5:159-175.
17. Reynolds LP, Grazul-Bilska AT, Redmer DA. Angiogenesis in the corpus luteum. Endocrine 2000; 12:1-9.
18. Wulff C, Wilson H, Largue P, Duncan WC, Armstrong DG, Fraser HM. Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, tie-2, and vascular endothelial growth factor messenger ribonucleic acid. J Clin Endocrinol Metab 2000; 85:4302-4309.
19. Mainsonpierre PC, Suri C, Jones PE, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. Angiopoitin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277:55-60.
20. Hata K, Udagawa J, Fujiwaki R, Nakayama K, Otani H, Miyazaki K. Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer. Oncology 2002; 62:340-348.
21. Stirling D, Waterman MR, Simpson ER. Expression of mRNA encoding basic fibroblast growth factor (bFGF) in bovine corpora lutea and cultured luteal cells. J Reprod Fertil 1991; 91:1-8.
22. Redmer DA, Reynolds LP. Angiogenesis in the ovary. Rev Reprod 1996; 1:182-192.
23. Yamamoto S, Konishi I, Nanbu K, Komatsu T, Mandai M, Kuroda H, Matsushita K, Mori T. Immunohistochemical localization of basic fibroblast growth factor (bFGF) during folliculogenesis in the human ovary. Gynecol Endocrinol 1997; 11:223-230.
24. Doraiswamy V, Knutson DL, Grazul-Bilska AT, Redmer DA, Reynolds LP. Fibroblast growth factor receptor (FGFR)-1 and -2 in the ovine corpus luteum throughout the estrous cycle. Growth Factors 1998; 16:125-135.
25. Peluso JJ, Pappalardo A, Fernandez G. Basic fibroblast growth factor maintains calcium homeostasis and granulosa cell viability by stimulating calcium efflux via a PKC delta-dependent pathway. Endocrinology 2001; 142:4203-4211.
26. Duncan WC. The human corpus luteum: remodelling during luteolysis and maternal recognition of pregnancy. Rev Reprod 2000; 5:12-17.
27. Ricke WA, Smith GW, Reynolds LP, Redmer DA, Smith MF. Matrix metalloproteinase (2, 9, and 14) expression, localization, and activity in ovine corpora lutea throughout the estrous cycle. Biol Reprod 2002; 66:1083-1094.
28. Dow MP, Bakke LJ, Cassar CA, Peters MW, Pursley JR, Smith GW. Gonadotropin surge-induced upregulation of the plasminogen activators (tissue plasminogen activator and urokinase plasminogen activator) and the urokinase plasminogen activator receptor within bovine periovulatory follicular and luteal tissue. Biol Reprod 2002; 66:1413-1421.
29. Hurwitz A, Lavy Y, Finci-Yeheskel Z, Milwidsky A, Shimonovitz S, Yagel S, Adashi EY, Laufer N, Mayer M. Interleukin-1-mediated stimulation of prostaglandin E production is without effect on plasminogen activator activity in human granulosa lutein cell cultures. J Clin Endocrinol Metab 1995; 80:3018-3024.
30. Vlodavsky I, Fuks Z, Bar-Ner M, Ariav Y, Schirrmacher V. Lymphoma cell-mediated degradation of sulfated proteoglycans in the sub-endothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Res 1983; 43:2704-2711.
31. Vlodavsky I. Preparation of extracellular matrices produced by cultured corneal endothelial and PF-HR9 endodermal cell. In: Bonifacino JS, Dasso M, Lippincott-Schwartz J, Harford J, Yamada KM (eds.), Current Protocols in Cell Biology, vol. 1. New York: John Wiley & Sons; 1999:10.14.11-10.14.14.
32. Clement BP. Ovary. In: Sternberg SS (ed.), Histology for Pathologists. New York: Raven Press; 1992: 777-784.
33. Fairbanks MB, Mildner AM, Leone JW, Cavey GS, Mathews WR, Drong RF, Slightom JL, Bienkowski MJ, Smith CW, Bannow CA, Heinrikson RL. Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer. J Biol Chem 1999; 274:29587-29590.
34. Zetser A, Levy-Adam F, Kaplan V, Gingis-Velitski S, Bashenko Y, Schubert S, Flugelman MY, Vlodavsky I, Ilan N. Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci 2004; 117:2249-2258.
35. Mundhenke C, Meyer K, Drew S, Friedl A. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol 2002; 60:185-194.
36. Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning and expression of a novel LH-induced mitochondrial protein in MA-10 mouse Leydig tumor cells: characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 1994; 269:28314-28322.
37. Friedmann Y, Vlodavsky I, Aingorn H, Aviv A, Peretz T, Pecker I, Pappo O. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucusa and stroma. Evidence for its role in colonic tumorigenesis. Am J Pathol 2000; 157:1167-1175.
38. Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, Naparstek Y, Cohen IR, Fuks Z. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 1992; 12:112-127.
39. Goldshmidt O, Nadav L, Aingorn H, Irit C, Feinstein N, Ilan N, Zamir E, Geiger B, Vlodavsky I, Katz BZ. Human heparanase is localized within lysosomes in a stable form. Exp Cell Res 2002; 281:50-62.
40. Goldshmidt O, Zcharia E, Aingorn H, Guetta-Rangini Z, Atzmon R, Michal I, Pecker I, Mitrani E, Vlodavsky I. Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence. J Biol Chem 2001; 276:29178-29187.
41. Ronen-Fuhrmann T, Timberg R, King RS, Hales HK, Hales BD, Stocco MD, Orly J. Spatio-temporal expression pattern of steroidogenic acute regulatory protein (StAR) during follicular development in the rat ovary. Endocrinology 1997; 139:303-315.
42. Ginath S, Menczer J, Friedmann Y, Aingorn H, Aviv A, Tajima K, Dantes A, Glezerman M, Vlodavsky I, Amsterdam A. Expression of heparanase, Mdm2, and erbB2 in ovarian cancer. Int J Oncol 2001; 18:1133-1144.
43. Ikeguchi M, Hirooka Y, Kaibara N. Heparanase gene expression and its correlation with spontaneous apoptosis in hepatocytes of cirrhotic liver and carcinoma. Eur J Cancer 2003; 39:86-90.
44. Zcharia E, Metzger S, Chajek-Shaul T, Aingorn H, Elkin M, Friedmann Y, Weinstein T, Li JP, Lindahl U, Vlodavsky I. Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior. FASEB J 2004; 18:252-263.